Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Matsuura, N
Right arrow Articles by Takagi, H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsuura, N
Right arrow Articles by Takagi, H
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology, Vol 27, Issue 3 135-139, Copyright © 1997 by Foundation for Promotion of Cancer Research

ORIGINAL ARTICLE

Increased level of circulating adhesion molecules in the sera of breast cancer patients with distant metastases

N Matsuura, T Narita, C Mitsuoka, N Kimura, R Kannagi, T Imai, H Funahashi and H Takagi
Department of Surgery II, Nagoya University School of Medicine, Japan.

The adhesion of circulating cancer cells to the vascular endothelium is an important at step in the hematogenous metastasis of cancer. E-selectin expressed on endothelial cells and carbohydrate ligands expressed on cancer cells mediate this adhesion. We investigated the clinical significance of such cell adhesion molecules in breast cancer. The cytosol concentration of sialyl Lewis(x) was found more elevated in cancerous tissue than that in adjacent non-cancerous tissue. In the serum, sialyl Lewis(x) and soluble E-selectin were seen elevated in patients with advanced and recurrent breast cancer, especially in those with distant metastases. From the above, we have concluded that sialyl Lewis(x) and soluble E-selectin could be used as tumor markers with a close relationship to the metastasis of breast cancer.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 GlycobiologyHome page
U. M Abd Hamid, L. Royle, R. Saldova, C. M Radcliffe, D. J Harvey, S. J Storr, M. Pardo, R. Antrobus, C. J Chapman, N. Zitzmann, et al.
A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression
Glycobiology, December 1, 2008; 18(12): 1105 - 1118.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. Ramaswamy, A. D. Elias, N. T. Kelbick, A. Dodley, M. Morrow, M. Hauger, J. Allen, C. Rhoades, K. Kendra, H. X. Chen, et al.
Phase II Trial of Bevacizumab in Combination with Weekly Docetaxel in Metastatic Breast Cancer Patients.
Clin. Cancer Res., May 15, 2006; 12(10): 3124 - 3129.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
J. Kurebayashi, T. Nomura, M. Hirono, S. Okubo, K. Udagawa, S. Shiiki, M. Ikeda, K. Nakashima, K. Tanaka, and H. Sonoo
Combined Measurement of Serum Sialyl Lewis X with Serum CA15-3 in Breast Cancer Patients
Jpn. J. Clin. Oncol., March 1, 2006; 36(3): 150 - 153.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Laferriere, F. Houle, M. M. Taher, K. Valerie, and J. Huot
Transendothelial Migration of Colon Carcinoma Cells Requires Expression of E-selectin by Endothelial Cells and Activation of Stress-activated Protein Kinase-2 (SAPK2/p38) in the Tumor Cells
J. Biol. Chem., August 31, 2001; 276(36): 33762 - 33772.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.